U S PHYSICAL THERAPY INC /NV financials

  1. Home
  2. Financials
  3. USPH
USPH CIK 0000885978

Source: EDGAR filings · Built 2026-06-02T04:17:46Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 60.99M 65.75M 72.68M 50.29M 68.20M 92.36M
EBITDA 109.07M 81.67M 66.21M 71.54M 82.24M 62.95M
Working Capital 950.00K 21.30M 131.19M 25.78M 11.69M -5.86M
Net Debt 279.60M 253.87M 105.76M 263.74M 194.51M 78.07M
Gross Margin 19.17% 18.46% 20.09% 20.25% 23.67% 22.33%
Operating Margin 11.10% 9.38% 8.35% 10.27% 14.27% 12.39%
Net Margin 5.07% 4.68% 4.67% 5.81% 8.25% 8.32%
Return on Equity (ROE) 8.31% 6.43% 5.93% 10.18% 13.81% 12.74%
Return on Assets (ROA) 3.29% 2.69% 2.83% 3.75% 5.45% 5.92%
Current Ratio 1.01× 1.18× 2.28× 1.30× 1.14× 0.94×
Debt-to-Equity 0.66× 0.60× 0.54× 0.94× 0.75× 0.40×
Effective Tax Rate 25.46% 24.26% 24.62% 21.89% 20.86% 19.88%
Cash Conversion Ratio 1.90× 2.38× 2.90× 1.82× 1.87× 2.84×
Accruals Ratio -0.03× -0.04× -0.05× -0.03× -0.05× -0.11×
SBC % of Revenue 1.06% 1.17% 1.20% 1.31% 1.59% 1.87%
CapEx Coverage 5.33× 8.16× 8.82× 7.10× 9.32× 13.09×
Free Cash Flow Per Share $4.02 $4.37 $5.12 $3.87 $5.29 $7.20

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 54.99× 48.21× 72.77× 36.01× 39.65× 48.49×
P/FCF 19.43× 20.32× 18.18× 20.92× 18.07× 16.71×
FCF Yield 5.15% 4.92% 5.50% 4.78% 5.53% 5.98%
EV / EBITDA 15.03× 21.91× 25.80× 20.92× 19.94× 30.02×
P/S 1.74× 2.29× 2.65× 2.23× 2.92× 4.28×
P/B 2.85× 3.14× 3.36× 3.90× 4.89× 6.56×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 780.99M 671.35M 604.80M 553.14M 495.02M 422.97M
Revenues 780.99M 671.35M 604.80M 553.14M 495.02M 422.97M
Gross Profit 149.69M 123.92M 121.51M 112.02M 117.18M 94.45M
Selling, General and Administrative Expense 69.26M 58.29M 51.95M 46.11M 46.53M 42.04M
Operating Income (Loss) 86.68M 62.99M 50.51M 56.80M 70.65M 52.41M
Income Tax Expense (Benefit) 19.81M 14.61M 12.16M 12.16M 15.27M 13.02M
Net Income (Loss) Attributable to Parent 39.58M 31.42M 28.24M 32.16M 40.83M 35.19M
Earnings Per Share, Basic $1.42 $1.84 $1.28 $2.25 $2.41 $2.48
Weighted Average Number of Shares Outstanding, Basic 15.18M 15.06M 14.19M 12.98M 12.90M 12.84M
Earnings Per Share, Diluted $1.42 $1.84 $1.28 $2.25 $2.41 $2.48
Weighted Average Number of Shares Outstanding, Diluted 15.18M 15.06M 14.19M 12.98M 12.90M 12.84M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 35.57M 41.36M 152.82M 31.59M 28.57M 32.92M
Assets, Current 139.99M 137.58M 233.38M 111.27M 95.17M 87.64M
Assets 1.20B 1.17B 997.24M 858.15M 749.43M 594.36M
Long-term Debt — — — — 118.42M 21.50M
Liabilities, Current 139.04M 116.28M 102.19M 85.49M 83.48M 93.49M
Long-term Debt, Excluding Current Maturities 152.59M 142.53M 138.99M 175.83M 117.59M 16.60M
Liabilities 433.81M 408.42M 345.00M 373.59M 296.98M 184.39M
Stockholders' Equity Attributable to Parent 476.43M 488.93M 476.19M 315.79M 295.61M 276.16M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 75.06M 74.94M 81.98M 58.54M 76.41M 100.00M
Net Cash Provided by (Used in) Investing Activities -36.71M -149.45M -45.02M -81.27M -124.14M -51.20M
Payments for Repurchase of Common Stock 5.57M 0 0 — — —
Net Cash Provided by (Used in) Financing Activities -44.14M -36.95M 84.27M 25.76M 43.38M -39.42M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (USPH CIK 0000885978), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

RMBS

RAMBUS INC

AXS

AXIS CAPITAL HOLDINGS LIMITED

HSY

HERSHEY CO